Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
Women's health companies drew a record $1.55 billion in disclosed equity investment in 2025, up 41% from $1.1 billion in 2024, according to a recent
$1.55B women's health 2025 (+41%), top-3 down to 32%: shift from concentrated to broad-based ecosystem. New categories (GLP-1, fertility) + Pfizer entry signal pharma-tech convergence; Series A funding gap blocks mid-stage scaling 2026.
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise

Venture capital funding for digital health startups is on an upswing, fueled by an AI-powered rebound following a post-pandemic…

The healthcare and life sciences industries’ collective push toward diversity, equity and inclusion continues as organizations…

The number of health services deals dipped in the first half of 2026 but deal value "remained resilient" as strategic acquirers…

At Fierce Healthcare, we keep track of all the venture capital being funneled into the health tech and digital health industries.…

Telehealth utilization increased 10.1% across the U.S. | The top five diagnostic categories were mental health, acute respiratory…

Patient collections are playing a bigger and bigger role in health systems’ total revenues, bringing a new focus on the…